Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Gains from Investment Securities (2020 - 2024)

Lantheus Holdings (LNTH) posted quarterly Gains from Investment Securities of -$1.3 million for Q4 2024, down 747.0% year-over-year from $200000.0 in Q1 2024, and down 1394.0% quarter-over-quarter from $100000.0 in Q2 2024.

Lantheus Holdings (LNTH) Gains from Investment Securities (2020 - 2024) Analysis & Trends

Lantheus Holdings (LNTH) has reported Gains from Investment Securities for 5 consecutive years, with -$1.3 million the latest figure, recorded in Q4 2024.

  • In Q4 2024, Gains from Investment Securities fell 747.0% year-over-year to -$1.3 million; the TTM figure through Dec 2024 stood at -$994000.0 (up 89.28% YoY), while the FY2024 annual figure was -$2.7 million, up 70.9% from the prior year.
  • Gains from Investment Securities slipped to -$1.3 million in Q4 2024 per LNTH's latest filing, from $100000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $43.9 million in Q4 2021 and bottomed at -$7.6 million in Q2 2023.
  • Historically, Gains from Investment Securities has averaged $5.9 million across 5 years, with a median of $250000.0 in 2021.
  • Annual changes were most pronounced in 2022 — Gains from Investment Securities jumped 6033.33% — and 2024, when it sank 747.0%.
  • Lantheus Holdings' Gains from Investment Securities stood at -$2.8 million in 2020, then surged by 1667.86% to $43.9 million in 2021, then plunged by 78.82% to $9.3 million in 2022, then sank by 97.85% to $200000.0 in 2023, then plunged by 747.0% to -$1.3 million in 2024.
  • Business Quant data shows LNTH's Gains from Investment Securities at -$1.3 million in Q4 2024, $100000.0 in Q2 2024, and $200000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.29 Mn
Dec 31, 2024 -1.29 Mn
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Dec 31, 2023 200,000.00
Dec 31, 2023 200,000.00
Sep 30, 2023 -500,000.00
Sep 30, 2023 -500,000.00
Jun 30, 2023 -7.58 Mn
Jun 30, 2023 -7.58 Mn
Mar 31, 2023 -1.40 Mn
Mar 31, 2023 -1.40 Mn
Dec 31, 2022 9.30 Mn
Dec 31, 2022 9.30 Mn
Sep 30, 2022 -1.50 Mn
Sep 30, 2022 -1.50 Mn
Jun 30, 2022 8.50 Mn
Jun 30, 2022 8.50 Mn
Mar 31, 2022 18.40 Mn
Mar 31, 2022 18.40 Mn